AdipoP−/−P mice develop less dermal fibrosis in response to bleomycin injection [149], and AdipoRon, a pharmacological inhibitor of adiponectin signaling, suppresses the bleomycin-dependent induction of SSc-like skin fibrosis, vasculopathy and immune abnormalities [150]. The gene discussed is ADIPOQ; the disease is systemic sclerosis.